GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vertex Pharmaceuticals Inc (XSWX:VRTX) » Definitions » Inventories, Finished Goods

Vertex Pharmaceuticals (XSWX:VRTX) Inventories, Finished Goods : CHF117 Mil (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Vertex Pharmaceuticals Inventories, Finished Goods?

Vertex Pharmaceuticals's quarterly finished goods declined from Jun. 2023 (CHF120 Mil) to Sep. 2023 (CHF102 Mil) but then increased from Sep. 2023 (CHF102 Mil) to Dec. 2023 (CHF117 Mil).

Vertex Pharmaceuticals's annual finished goods increased from Dec. 2021 (CHF80 Mil) to Dec. 2022 (CHF151 Mil) but then declined from Dec. 2022 (CHF151 Mil) to Dec. 2023 (CHF117 Mil).

Vertex Pharmaceuticals Inventories, Finished Goods Historical Data

The historical data trend for Vertex Pharmaceuticals's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vertex Pharmaceuticals Inventories, Finished Goods Chart

Vertex Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 33.64 65.12 79.85 150.73 116.75

Vertex Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 150.73 125.78 119.57 101.57 116.75

Vertex Pharmaceuticals Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Vertex Pharmaceuticals (XSWX:VRTX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vertex Pharmaceuticals Inc (XSWX:VRTX) » Definitions » Inventories, Finished Goods
Comparable Companies
REGN MRNA BNTX ALNY BGNE BMRN RPRX SRPT INCY UTHR OCSE:NOVO B ASX:CSL XKRX:207940 XKRX:068270 XBRU:UCB XBRU:ARGX OCSE:GMAB SHSE:603392 SZSE:300122 XKRX:028300
Traded in Other Exchanges
VRTX:USA VRTX:Mexico 1VRTX:Italy VX1d:UK VX1:Germany VRTX34:Brazil VRTX:Austria
Address
50 Northern Avenue, Boston, MA, USA, 02210
Website
https://www.vrtx.com
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using nonopioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.